Thermo Fisher Scientific Inc [TMO] stock is trading at $478.32, up 0.69%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The TMO shares have gain 15.33% over the last week, with a monthly amount glided 16.48%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Thermo Fisher Scientific Inc [NYSE: TMO] stock has seen the most recent analyst activity on July 24, 2025, when HSBC Securities downgraded its rating to a Hold but kept the price target unchanged to $510 for it. Previously, Scotiabank upgraded its rating to Sector Outperform on July 11, 2025, and kept the price target unchanged to $590. On July 09, 2025, downgrade downgraded it’s rating to Neutral but maintained its price target of $460 on the stock. Bernstein upgraded its rating to a Outperform but stick to its price target of $630 on January 10, 2025. Scotiabank initiated its recommendation with a Sector Perform. In a note dated October 01, 2024, Stephens initiated an Overweight rating and provided a target price of $680 on this stock.
Thermo Fisher Scientific Inc [TMO] stock has fluctuated between $385.46 and $627.88 over the past year. Currently, Wall Street analysts expect the stock to reach $592 within the next 12 months. Thermo Fisher Scientific Inc [NYSE: TMO] shares were valued at $478.32 at the most recent close of the market. An investor can expect a potential return of 23.77% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Thermo Fisher Scientific Inc [NYSE:TMO] reported sales of 43.21B for the trailing twelve months, which represents a growth of 2.98%. Gross Profit Margin for this corporation currently stands at 0.42% with Operating Profit Margin at 0.17%, Pretax Profit Margin comes in at 0.16%, and Net Profit Margin reading is 0.15%. To continue investigating profitability, this company’s Return on Assets is posted at 0.07, Equity is 0.13 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.7.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 473.95 points at the first support level, and at 469.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 483.15, and for the 2nd resistance point, it is at 487.97.
Ratios To Look Out For
For context, Thermo Fisher Scientific Inc’s Current Ratio is 1.93. Further, the Quick Ratio stands at 1.50, while the Cash Ratio is 0.36. Considering the valuation of this stock, the price to sales ratio is 4.18, the price to book ratio is 3.66 and price to earnings (TTM) ratio is 27.69.
Transactions by insiders
Recent insider trading involved Pettiti Gianluca, Officer, that happened on Jul 25 ’25 when 400.0 shares were purchased. Executive Vice President, Pettiti Gianluca completed a deal on May 12 ’25 to sell 400.0 shares. Meanwhile, Officer Pettiti Gianluca bought 400.0 shares on May 12 ’25.
